<

 
Data updated 2025-06-03 00:05:01
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date13731230.2 (espacenet)  (Federated)  (European Patent Register), 20130612
Patent/reg. no. and dateDK/EP 2861210, 20170503
Publication date20150422
Priority no. and dateUS 201261659211 P, 20120613, US 201361784382 P, 20130314
EP pub. no. and date EP 2861210 20150422
Effective date
Applicant/ownerIpsen Biopharm Limited, Ash Road,
Wrexham Industrial Estate,
Wrexham LL13 9UF, GB
Applicant ref. no.61888DK01
InventorFITZGERALD, Jonathan, Basil, 32 Magnolia Street
Arlington, MA 02474, US,
MOYO, Victor, 2 Neshanic Dr.
Ringoes, NJ 08551, US,
BAYEVER, Eliel, 225 West 60th Street PH1D
New York, NY 10023, US,
DHINDSA, Navreet, 190 Bolton Street
Boston, MA 02127, US,
NIYIKIZA, Clet, 326 Overlook Lane
Gulph Mills, PA 19428, US,
LAIVINS, Peter, 22 Bridle Lane
Scituate, MA 02066, US,
KIM, Jaeyeon, 30 Donald Street
Lexington, MA 02420, US
RepresentativePlougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK
Opponent
IPC ClassA61K 31/4745 (2006.01) , A61K 31/513 (2006.01) , A61K 31/517 (2006.01) , A61K 9/00 (2006.01) , A61P 35/00 (2006.01) 
TitleFremgangsmåde til behandling af cancer i bygspytkirtlen under anvendelse af kombinationsbehandlinger omfattende liposomal irinotecan
Int. application no.US2013045495
Int. publication no.WO2013188586
Related patent (certificate)
StatusOphævet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact